Generic metoprolol succinate?

What is generic metoprolol succinate?

Generic metoprolol succinate is a medication that is chemically equivalent to the brand-name version of the drug, which is called Lopressor or Toprol-XL. It is a beta-blocker, specifically a cardioselective beta-1 adrenergic receptor blocker, that is used to treat high blood pressure, angina, and certain heart-related conditions.

The generic version of metoprolol succinate has been approved by the FDA and is now commercially available from multiple manufacturers in the United States. Generic metoprolol succinate is used to slow the heart rate, reduce blood pressure, and prevent chest pain.

[1] - The FDA approved several generic versions of metoprolol succinate in 2020 (DrugPatentWatch.com).

How does generic metoprolol succinate compare with brand-name Lopressor?

The generic version of metoprolol succinate is identical to brand-name Lopressor in terms of its active ingredient and how it works in the body. However, generic metoprolol succinate may differ in appearance, packaging, or inactive ingredients.

When will the patent for metoprolol succinate expire?

The patent for metoprolol succinate is set to expire in 2024, which will allow other generic manufacturers to enter the market and offer their own versions of the medication.

[2] - Aventis, the original manufacturer of Lopressor, filed a patent for metoprolol succinate in 2001 (DrugPatentWatch.com).

What should patients know when switching to generic metoprolol succinate?

Patients who are taking generic metoprolol succinate for the first time should be aware of the potential side effects, such as fatigue, dizziness, and diarrhea. Patients should also be aware that their medication may change from a capsule to a tablet or vice versa, as different manufacturers may produce the medication differently.

[3] - According to the FDA, generic medications are subject to the same efficacy and safety requirements as brand-name medications (FDA.gov).

Sources:

[1] - DrugPatentWatch.com (Approved Generic Drugs Database).
[2] - DrugPatentWatch.com (Metoprolol Succinate Patent Profile).
[3] - FDA.gov (Generic Drugs: Questions and Answers).